NAM
AVNS

Nexpoint Asset Management’s Avanos Medical AVNS Stock Holding History

Nexpoint Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.2M Buy
+2,177,366
New +$51M 3.62% 11

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Nexpoint Asset Management's AVNS Position: Q2 2026 in Review

Nexpoint Asset Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 2,177,366 shares worth $54.2M. The stake represents 3.62% of the portfolio and ranks #11 among its holdings.

266 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Nexpoint Asset Management held 2,177,366 shares of Avanos Medical worth $54.2M as of Q2 2026.
  • Avanos Medical was a new Nexpoint Asset Management position in Q2 2026.
  • Avanos Medical made up 3.62% of Nexpoint Asset Management's portfolio in Q2 2026, its #11 holding.
  • 266 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Nexpoint Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.